Skip to content

Public FDA record

Z-3250-2026: ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI code: 00690103210927 The non-invasive ForeSigh

Recall record Z-3250-2026 for Becton, Dickinson and Company. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-3250-2026
Company in FDA record
Becton, Dickinson and Company
FDA classification date
Sep 21, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Due to incorrect switching of Channel 1 and 2 on the module and flag labels on the tissue oximetry cables.

Source facts

Action
On 08/11/2026, an "URGENT: Medical Device Correction" letter was email or FedEx'd informing customer that, based on customer feedback, BD has identified that during manufacturing, the laterality identification labels may be missing or inaccurately placed on the device. There is potential that the labels on the green cables may have been switched, with the channel 1 cable labeled as channel 2, and the channel 2 cable labeled as channel 1. This will lead to a mismatch as to the left and right values displayed on the monitor and what the labels indicate on the cables. Customers are instructed to check devices in clinical use and in inventory: 1. Verify for the presence of the flag, sensor, and channel labels on the device. 2. Verify that the flag and sensor labels correspond to the correct channel label on the housing (See picture included in the customer notification for correct label placement). 3. If either of the labels are missing, or the flag label and/or the sensor label do not match the channel label on the housing, contact Technical Support for further assistance. If the flag and sensor labels correctly correspond to the channel labels, as seen in the pictures, there is no further action required. 4. Provide a copy of this notification to any customers and/or facilities you may have distributed devices to. 5. Post this notice on or segregate the impacted unit(s) until correction is completed. 6. Complete the attached Customer Response Form and return it to the BD contact noted on the form whether or not you have any of the impacted products so that BD may acknowledge your receipt of this notification. For questions for assistance: Recall Customer Response Forms - Fax: 1-312-949-0410; Email: BDRC20@bd.com Technical/Product Complaints - Phone: 1.800.822.9837 Email: SMB-Complaints_US_APM@bd.com
Initiated
2026-08-11
Root cause
Labeling mix-ups
Distribution
Worldwide - U.S Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY. The country of Grand Cayman.
Recall number
Z-3250-2026
Recall status
Open, Classified
CDRH record ID
221435
FDA classified
2026-09-21
Recall event number
99370

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗